Find a Doctor
Brad A. Racette, MD, FAAN
- (602) 406-6262
- Fax: (602) 406-6261
Brad A. Racette, MD, FAAN, is a neurologist in the Muhammad Ali Parkinson Center, the Kemper and Ethel Marley Professor, and Chair of Neurology at Barrow Neurological Institute. He is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Racette’s clinical expertise includes the diagnosis and management of all types of movement disorders, and he has more than 30 years of experience in the use of botulinum toxin for limb disorders. He is a fellow of the American Academy of Neurology and the American Neurological Association. He is the past chairman of the Neurological, Aging, and Musculoskeletal Epidemiology Study Section at the National Institutes of Health (NIH) and a current member of the National Advisory Environmental Health Sciences Council for the National Institute of Environmental Health Sciences. He has served as an advisor for numerous international regulatory agencies. He is an honorary professor of public health at the University of Witwatersrand in Johannesburg, South Africa, and a professor emeritus at Washington University.
Dr. Racette earned his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago and his bachelor’s degree in molecular biology from Princeton University in New Jersey. He completed his neurology residency and a fellowship in movement disorders at Washington University School of Medicine in St. Louis. He then joined the faculty at Washington University, where he held the roles of Robert Allan Finke professor of neurology and executive vice-chairman of neurology.
Dr. Racette’s research focuses on manganese neurotoxicity, environmental risk factors for Parkinson’s disease, and administrative data studies of Parkinson’s disease and other neurologic diseases. He has authored over 175 peer-reviewed publications. He is supported by the NIH, Michael J. Fox Foundation, Department of Defense, Cure Alzheimer’s Fund, Northeast ALS Consortium, and American Parkinson Disease Association.
- Fellowship, Washington University School of Medicine, Department of Neurology, Section of Movement Disorders, 1996-1998
- Residency, Washington University School of Medicine, Neurology, 1993-1996
- Internship, Northwestern Memorial Hospital, Internal Medicine, 1992-1993
- MD, Northwestern University, Feinberg School of Medicine, 1992
- BA, Princeton University, Molecular Biology, 1988
- Fellow, American Academy of Neurology
- Member, Huntington Study Group
- Member, Parkinson’s Study Group
- Keystone Lecture, National Institute of Environmental Health Sciences, 2016
- Zaffarano Lecture, Iowa State University, 2015
- Hanninen Lecture, International Congress of Occupational Health Scientific Committee on Neurotoxicology and Psychophysiology, Cape Town, South Africa, 2013
- Top Doctor, Castle Connolly, 2014-2021
- Top Doctor, S. News and World Report, 2012-2022
- Top Provider, Washington University, 2010
- Fellow, American Neurological Association, 2004
- Fellow in Neuropharmacology, Seay Foundation, 1996-1997, 1997-1998
- Alpha Omega Alpha, Northwestern University Medical School Chapter, 1991
- Cum Laude, Princeton University, 1988
- Class of 1961 Scholarship, Princeton University, 1987
- Angus and Elizabeth Williams’ Scholarship, Princeton University, 1986
A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
Date: 05/2023
Authors: Irene Faust, Mark Warden, Alejandra Camacho-Soto, Brad A. Racette, Susan Searles Nielsen
Neuroinflammation and white matter alterations in occupational manganese exposure assessed by diffusion basis spectrum imaging
Date: 04/2023
Authors: Susan R. Criswell, S R Criswell, Susan Searles Nielsen, Irene M. Faust, Joshua S. Shimony, Robert L. White, Jason Lenox-Krug, Brad A. Racette
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse Model.
Date: 01/2023
Authors: Collin J Kreple, Susan Searles Nielsen, Kathleen M Schoch, Tao Shen, Mark Shabsovich, Yizhe Song, Brad A Racette, Timothy M Miller
Incidence of Amyotrophic Lateral Sclerosis in Older Adults.
Date: 06/2022
Authors: Alejandra Camacho-Soto, Susan Searles Nielsen, Irene M Faust, Robert C Bucelli, Timothy M Miller, Brad A Racette
Environmental manganese exposure and cognitive control in a South African population
Date: 03/2022
Authors: Brad A. Racette, Gill Nelson, Wendy W. Dlamini, Tamara Hershey, Pradeep Prathibha, Jay R. Turner, Harvey Checkoway, Lianne Sheppard, Susan Searles Nielsen
- English
- (602) 406-6262
- Fax: (602) 406-6261
Brad A. Racette, MD, FAAN
- (602) 406-6262
- Fax: (602) 406-6261
Brad A. Racette, MD, FAAN, is a neurologist in the Muhammad Ali Parkinson Center, the Kemper and Ethel Marley Professor, and Chair of Neurology at Barrow Neurological Institute. He is board certified in neurology by the American Board of Psychiatry and Neurology.
Dr. Racette’s clinical expertise includes the diagnosis and management of all types of movement disorders, and he has more than 30 years of experience in the use of botulinum toxin for limb disorders. He is a fellow of the American Academy of Neurology and the American Neurological Association. He is the past chairman of the Neurological, Aging, and Musculoskeletal Epidemiology Study Section at the National Institutes of Health (NIH) and a current member of the National Advisory Environmental Health Sciences Council for the National Institute of Environmental Health Sciences. He has served as an advisor for numerous international regulatory agencies. He is an honorary professor of public health at the University of Witwatersrand in Johannesburg, South Africa, and a professor emeritus at Washington University.
Dr. Racette earned his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago and his bachelor’s degree in molecular biology from Princeton University in New Jersey. He completed his neurology residency and a fellowship in movement disorders at Washington University School of Medicine in St. Louis. He then joined the faculty at Washington University, where he held the roles of Robert Allan Finke professor of neurology and executive vice-chairman of neurology.
Dr. Racette’s research focuses on manganese neurotoxicity, environmental risk factors for Parkinson’s disease, and administrative data studies of Parkinson’s disease and other neurologic diseases. He has authored over 175 peer-reviewed publications. He is supported by the NIH, Michael J. Fox Foundation, Department of Defense, Cure Alzheimer’s Fund, Northeast ALS Consortium, and American Parkinson Disease Association.
- (602) 406-6262
- Fax: (602) 406-6261
- Fellowship, Washington University School of Medicine, Department of Neurology, Section of Movement Disorders, 1996-1998
- Residency, Washington University School of Medicine, Neurology, 1993-1996
- Internship, Northwestern Memorial Hospital, Internal Medicine, 1992-1993
- MD, Northwestern University, Feinberg School of Medicine, 1992
- BA, Princeton University, Molecular Biology, 1988
- Fellow, American Academy of Neurology
- Member, Huntington Study Group
- Member, Parkinson’s Study Group
- Keystone Lecture, National Institute of Environmental Health Sciences, 2016
- Zaffarano Lecture, Iowa State University, 2015
- Hanninen Lecture, International Congress of Occupational Health Scientific Committee on Neurotoxicology and Psychophysiology, Cape Town, South Africa, 2013
- Top Doctor, Castle Connolly, 2014-2021
- Top Doctor, S. News and World Report, 2012-2022
- Top Provider, Washington University, 2010
- Fellow, American Neurological Association, 2004
- Fellow in Neuropharmacology, Seay Foundation, 1996-1997, 1997-1998
- Alpha Omega Alpha, Northwestern University Medical School Chapter, 1991
- Cum Laude, Princeton University, 1988
- Class of 1961 Scholarship, Princeton University, 1987
- Angus and Elizabeth Williams’ Scholarship, Princeton University, 1986
A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
Date: 05/2023
Authors: Irene Faust, Mark Warden, Alejandra Camacho-Soto, Brad A. Racette, Susan Searles Nielsen
Neuroinflammation and white matter alterations in occupational manganese exposure assessed by diffusion basis spectrum imaging
Date: 04/2023
Authors: Susan R. Criswell, S R Criswell, Susan Searles Nielsen, Irene M. Faust, Joshua S. Shimony, Robert L. White, Jason Lenox-Krug, Brad A. Racette
Protective Effects of Lovastatin in a Population-Based ALS Study and Mouse Model.
Date: 01/2023
Authors: Collin J Kreple, Susan Searles Nielsen, Kathleen M Schoch, Tao Shen, Mark Shabsovich, Yizhe Song, Brad A Racette, Timothy M Miller
Incidence of Amyotrophic Lateral Sclerosis in Older Adults.
Date: 06/2022
Authors: Alejandra Camacho-Soto, Susan Searles Nielsen, Irene M Faust, Robert C Bucelli, Timothy M Miller, Brad A Racette
Environmental manganese exposure and cognitive control in a South African population
Date: 03/2022
Authors: Brad A. Racette, Gill Nelson, Wendy W. Dlamini, Tamara Hershey, Pradeep Prathibha, Jay R. Turner, Harvey Checkoway, Lianne Sheppard, Susan Searles Nielsen
- English